
More info on drug review timelines? HHS and FDA pull Trump HHS’ last-minute pledge
HHS and FDA on Friday said they’re withdrawing a notice published just days before former President Donald Trump left office, which would’ve required the FDA to publish redundant information on the timelines for reviewing drug applications.
In addition to the FDA being entirely left out of the decision to publish the initial notice, the decision to pull the notice came as HHS and FDA said it did not account for what’s already publicly available about FDA’s review of drug applications.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.